Abdel- Rahman, A. O.; Farag, M. A.; Samira El- Kilany; Eman, M. A.; Manal Abo El- Yazed and Zeidan, S. (2006): Isolation and Identification of FMDV during an outbreak of 2006 in Egypt. Kafr El- Sheikh Vet. Med. J.; 4(1): 2006.
Ahmed, H.A., S.A.H. Salem, A.R. Habashi, A.A. Arafa and M.G.A. Aggour et al., 2012. Emergence of foot-and-mouth disease virus SAT 2 in Egypt during 2012. Transboundary Emerg. Dis., 59: 476-481
Allende, A.J. Mende da silva ,G,Comparsie (2003) : South American standards for foot and mouth disease vaccine quality . Scientifiques et medicaies Els evier SAS. 331 -336 .
Ayyappan, S.R., R. Srikumar and R. Thangaraj (2010): International Journal of Microbiology Research, 1(2), 67-71
Barnett, P.V, Pullen, L., Statham, R. and Salt J.(1996): Preliminary studies on ‘emergency’ foot-and-mouth disease vaccines formulated with metabolizable or semi- metabolizable oil adjuvants. Report, Session Group of the Standing Technical Committee of the European Commission For The Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Israel, 1996.
Belsham, G.J. (1993): Distinctive features of FMDV, a member of the Picorna virus family, aspects of virus protein synthesis, protein processing and structure. Progress in Biophysics and Molecular Biology 60: 241-260.
Code of Federal regulation of USA (1986) : Published by the office of the federal register national archives and Record administration , Animal and animal products 9 / 1986.
Committee of official Laboratories and Drug Control Services (1980): Third joint report of the Committee of Official Laboratories and Drug Control Services and the Section of Industrial Pharmacists-FIP (1980) The test for the eflectiveness of antimicrobial preservation of pharmaceuticals. fhummaceutica Acta Helvetiae,55.4049.
El-Shehawy, L.I., H.I. Abu-Elnaga, S.A. Rizk, A.S. Abd El-Kreem, A.A. Mohamed and H.G. Fawzy, (2014) : Molecular differentiation and phylogenetic analysis of the Egyptian foot-and-mouth disease virus SAT2. Arch. Virol., 159: 437-443.
FAO (2012). Foot-and-mouth disease caused by serotype SAT2 in Egypt and Libya. Empres watch, Vol. 25 – March 2012.
Farag, M.A., Aggour, M. A. and Daoud, A.M. (2005): ELISA as a rapid method for detecting the correlation between the field isolates of FMD and the current used vaccine strain in Egypt. Vet. Med. J. Giza, Vol. 53 no. 4: 949- 955.
Gatsing, D., D.,J. A. Mbah, I. H. Garba, P. Tane, P. Djemgou and B. F. Nji-Nkah (2006) : “An Antisalmonellal Agent from the Leaves of Glossocalys. Brevipes Benth (Monimiaceae),” Pakistan Journal of Biological Sciences, Vol. 9, No. 1, 2006, pp. 84-87.
Ghoneim, N.H., Abdel-Karim, A.K.M., El-Shehawy, L., Abdel-Moein, K.A. 2010. Foot and Mouth Disease in Animals in Sharkia Governorate – Egypt. Transbound. Emerg. Dis. 57: 19-21.
Hamblin C, Barnett I T R and Crowther J R (1986): Anew Enzyme-Linked Immuno Sorbent Assay (ELISA) for the detection of antibodies against FMD virus. П Application. Journal of immunological methods, 93: 123-129.
Hema, T.A., A.S. Arya, Subha Suseelan, R.K. John Cesestinal and P.V. Divya (2013): Int. J.
Pharm. Bio. Sci., 4(1), 70-80.
Josephin Sheeba, B. and T. Selva Mohan (2012): Asian J. Plant Sci. Res., 2(2), 83-88.
Kallings. L.O., Ringertz, O., Silverstolpe. L.& Ernerfeldt, F.( 1966): Microbiological contamination of medical products. Acta fharrnaceutica Suecica. 3.7 19-228.
Kandeil, A., R. El-Shesheny, G. Kayali, Y. Moatasim and O. Bagato (2013) : Characterization of the recent outbreak of foot-and-mouth disease virus serotype SAT2 in Egypt. Arch. Virol., 158: 619-627.
Karber. G (1931):Beitrage Zurich kille kiven behand-lung pharmakologis reihenver-suche nanny shied berg.Arch.Exp.Path.pharmak; 126:280-283.
Knowles, N.J., J. Wadsworth, S.M. Reid, K.G. Swabey and A.A. El-Kholy ( 2007) : Foot-and-mouth disease virus serotype A in Egypt. Emerg. Infect. Dis., 13: 1593-1596.
Lynch, M.. Lund,\V. & Wilson, D.A. (1977): Chloroform as a preservative in aqueous systems. Phurmaceuti-ral Journal, 219,507-5 10.
Martindale (2007): The Complete Drug Reference, Sweetman S.C. Ed., 35th edn., pharmaceutical Press, London 2007.
Mousa,A.A.;Boulaus,S.M.;Elsayed;,F.S.andBohm,H.O.(1974): Typing and subtyping of a strain of FMD isolated from sharquia province, 1970.J.egypt,assuit Veterinary Medicine, Vol.(34) No.(3-4) : (413-419).
Nair,S.P. and Sen,A.K. (1992): “A comparative study on the immune response of sheep to FMD virus vaccine type Asia1 prepared with different inactivators and adjuvants”. Comp. Immunol. Microbiol. Infect. Dis., 15(2): 117-124.
Nweze, E. T., J. I. Okafor and O.J. Njoku (2004): Bio. Res. Biotechnol., 2(1), 34.
Orsel,K.;deJong,M.C.;Bouma,A.;Stegeman,J.A.andDekker,A.(2007): Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs. Vaccine2 21;25(34):6381-91.
OIE(2000) : OIE manual of standards : Anon. Section 2.1. List - Diseases, Chapter 2.1.1. Foot-and-mouth disease. OIE manual of standards for diagnostic tests and vaccines; 4th Ed. 2000, Paris,77-92
OIE (2009) : Terrestrial Manual 2009 (5), Foot and mouth disease (Chapter 2.1.5.) (1-29).
Parekh, J., D. Jadeja and S. Chanda (2005) :Turkish Journal of Biology, 29, 203-210.
Pharmaceutical Society Working Party (1971): Microbial contamination in harmaceuticals for oral and topical use: report of the Pharmaceutical Society’s working party. hannaceuiical Jorrrnal, 207,400-402.
Public Health Laboratory Service Working Party (1971): Microbial contamination of medicines adminis-tered to hospital patients: report of the Public Health Laboratory Service working party. Fhurmaceutical Journal, 207,9699.
Rajakaruna, N., C.S. Harris and G.H.N. Towers (2002). Pharmaceutical Biology, 40, 235-244.
Reddy, G.S.; K.Ananda Rao and VA Srinivasan (2001 ): Performance of oil adjuvant combined vaccine containing FMD, rabies, Pasteurella multocida and Clostridium chauvoei antigens . Indian veterinary journal · November 2001 : 78: 990 993
Rybacki E., Stozek T.(1980):Excipients in the tech-nology of drug forms (Polish), Biblioteka far-maceuty Vol. 7, PZWL, Warszawa 1980.
Shastri R. V. and Varudkar, J. S (2009) :Synthesis and Antim-icrobial Activity of 3-Propen-1,2-benzisoxazole Deriva-tives,” Indian Journal of Chemical Sciences, Vol. 48B, 2009, pp. 1156-1160.
Shawky M., Abd El-Aty M., Hiam. M. Fakry, Hind M. Daoud, Ehab El-Sayed I., Wael Mossad G., Sonia A. Rizk, Abu-Elnaga H., Mohamed A. A., Abd El-kreem A. and Farouk E. M. (2013) : Isolation and Molecular Characterization of Foot and Mouth Disease SAT2 Virus during Outbreak 2012 in Egypt . J Vet Adv 2013, 3(2): 60-68
Thc Pharmaceutical Codex (1979): I Ith edition. pp. 175 and xvi. The Pharmaceutical Press, London.
Vedhanarayanan, P., T. Vaithiyanathan and P. Sundaramoorthy (2015) : Antimicrobial activity of chloroform and methanol extract of lennea coromandelica merr. International Letters of Natural Sciences Online: 2015-08-28 ISSN: 2300-9675, Vol. 45, pp 67-74.
Vinoth, B. and R. Manivasagaperumal (2015): Int. J. Pharm. Bio. Sci., 6(2), 613-620.
Zahran, G.E.D. (1960): Foot and mouth disease in southern region of URA.Bull. Off. Int. Epiz., 13: 390- 393.